Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation ...

Please provide your email address to receive an email when new articles are posted on . There were 282 million malaria cases reported globally in 2024. WHO’s 2025 malaria report links antimalarial ...

The first three-dimensional image capturing a critical malaria 'conductor' protein could lead to the development of a new class of antimalarial drugs. Researchers from Melbourne's Walter and Eliza ...

Aminopeptidases constitute a diverse family of enzymes responsible for cleaving N‐terminal amino acids from peptide substrates, a process central to protein turnover and nutrient acquisition in ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. GENEVA (AP) — Switzerland’s medical products ...

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects millions of people worldwide, including about 8–13% of reproductive-aged women, according to the World Health Organization.

Professor Sir Nick White, who has died of cancer aged 74, was an expert on tropical diseases and played a leading role in transforming treatments for malaria, saving millions of lives.

Suggested Citation: "Appendix B: Invited Presentations." National Academies of Sciences, Engineering, and Medicine. 2020. Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for ...

Darryl Head was named by the First Coast YMCA as its next president and CEO. GENEVA – Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small ...